As anticipated, this corresponds directly to active studies targeting these pathways for treatment of AIH, with 4 clinical trials listed on ClinicalTrials.gov examining the role of IL-2, IL-17, and Treg biology in AIH. This evidence concerns the gene IL17A and autoimmune hepatitis.